Basic Information | Post buying leads | Suppliers | Cas Database |
Name |
Doxapram |
EINECS | 206-216-3 |
CAS No. | 309-29-5 | Density | 1.104 g/cm3 |
PSA | 32.78000 | LogP | 3.04910 |
Solubility | N/A | Melting Point |
N/A |
Formula | C24H30N2O2 | Boiling Point | 536.4 °C at 760 mmHg |
Molecular Weight | 378.514 | Flash Point | 278.2 °C |
Transport Information | N/A | Appearance | N/A |
Safety | Risk Codes | N/A | |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
2-Pyrrolidinone,1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl- (7CI,8CI);1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone;Doxapram; |
Article Data | 4 |
The CAS register number of Doxapram is 309-29-5. It also can be called as 2-Pyrrolidinone, 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl- and the IUPAC name about this chemical is 1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one. The molecular formula about this chemical is C24H30N2O2 and the molecular weight is 378.51. Classification code about this chemical are Central Nervous System Agents, Central nervous system stimulants, Drug / Therapeutic Agent, Reproductive Effect and Respiratory system agents. This chemical is a central respiratory stimulant with a brief duration of action. It can be used in intensive care settings to stimulate the respiratory rate in patients with respiratory failure.
Physical properties about Doxapram are: (1)ACD/LogP: 3.23; (2)ACD/LogD (pH 5.5): 1.15; (3)ACD/LogD (pH 7.4): 2.8; (4)ACD/BCF (pH 5.5): 1.39; (5)ACD/BCF (pH 7.4): 62.86; (6)ACD/KOC (pH 5.5): 11.27; (7)ACD/KOC (pH 7.4): 510.58; (8)#H bond acceptors: 4; (9)#Freely Rotating Bonds: 6; (10)Polar Surface Area: 32.78Å2; (11)Index of Refraction: 1.562; (12)Molar Refractivity: 111.22 cm3; (13)Molar Volume: 342.8 cm3; (14)Polarizability: 44.09x10-24cm3; (15)Surface Tension: 41.8 dyne/cm; (16)Enthalpy of Vaporization: 81.31 kJ/mol; (17)Boiling Point: 536.4 °C at 760 mmHg; (18)Vapour Pressure: 1.4E-11 mmHg at 25°C.
You can still convert the following datas into molecular structure:
(1)SMILES: O=C4N(CC)CC(CCN1CCOCC1)C4(c2ccccc2)c3ccccc3
(2)InChI: InChI=1/C24H30N2O2/c1-2-26-19-22(13-14-25-15-17-28-18-16-25)24(23(26)27,20-9-5-3-6-10-20)21-11-7-4-8-12-21/h3-12,22H,2,13-19H2,1H3
(3)InChIKey: XFDJYSQDBULQSI-UHFFFAOYAU
(4)Std. InChI: InChI=1S/C24H30N2O2/c1-2-26-19-22(13-14-25-15-17-28-18-16-25)24(23(26)27,20-9-5-3-6-10-20)21-11-7-4-8-12-21/h3-12,22H,2,13-19H2,1H3
(5)Std. InChIKey: XFDJYSQDBULQSI-UHFFFAOYSA-N
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 268mg/kg (268mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Journal of Pharmacy and Pharmacology. Vol. 30, Pg. 522, |